EP3251672
PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE AND PREPARATION METHOD THEREFOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.12.2015EP published:
1.2.2023EP application number:
15875281.6
EPO information:
European Patent Register
Max expiry date:
30.12.2035
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE AND PREPARATION METHOD THEREFORLanguage of the patent:
English
Timeline
Today
31.12.2015EP application
1.2.2023EP Publication
Owner
Name:
Shenzhen Pharmacin Co., Ltd.Address:
Suite 2-303, Bio-incubator 10 Gaoxin Central 1st Ave Nanshan District, Shenzhen, Guangdong 518057, CN
Inventor
Name:
WANG, ZerenAddress:
Kunming Yunnan 650106, CN
Name:
ZHAO, YulanAddress:
Kunming Yunnan 650106, CN
Name:
WANG, LijiangAddress:
Kunming Yunnan 650106, CN
Name:
ZHANG, XiaoAddress:
Kunming Yunnan 650106, CN
Name:
XU, JunAddress:
Kunming Yunnan 650106, CN
Name:
CHEN, ShunqinAddress:
Kunming Yunnan 650106, CN
Name:
SUN, MeiliAddress:
Kunming Yunnan 650106, CN
Name:
JIANG, GuishengAddress:
Kunming Yunnan 650106, CN
Priority
Number:
201410853865Date:
31.12.2014Country:
CN
Number:
201510988362Date:
25.12.2015Country:
CN
Classification
Categories:
A61K 31/4439, A61K 31/185, A61P 7/02, A61K 47/12